Overview

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Status:
Completed

Trial end date:
2013-05-01

Target enrollment:

Participant gender:

Summary

This purpose of this study is to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca
Pfizer

Collaborator:

Forest Laboratories

Treatments:

Ceftaroline fosamil
Ceftriaxone